Views & Analysis Graph power: life sciences lead in intelligent data use Graph technology is allowing pharma to model data in a way that offers invaluable insights for marketing, R&D and compliance teams alike.
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face